PE20060074A1 - Derivados de (indol-3-il)-heterociclos - Google Patents

Derivados de (indol-3-il)-heterociclos

Info

Publication number
PE20060074A1
PE20060074A1 PE2005000245A PE2005000245A PE20060074A1 PE 20060074 A1 PE20060074 A1 PE 20060074A1 PE 2005000245 A PE2005000245 A PE 2005000245A PE 2005000245 A PE2005000245 A PE 2005000245A PE 20060074 A1 PE20060074 A1 PE 20060074A1
Authority
PE
Peru
Prior art keywords
alkyl
indol
methyl
tetrahydropyran
chloro
Prior art date
Application number
PE2005000245A
Other languages
English (en)
Inventor
Julia Adam-Worrall
Angus John Morrison
Takao Kiyoi
Duncan Robert Mcarthur
Grant Wishart
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of PE20060074A1 publication Critical patent/PE20060074A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

REFERIDA A COMPUESTOS (INDOL-3-IL)-HETEROCICLO DE FORMULA I DONDE A ES ANILLO HETEROCICLICO DE 5 MIEMBROS; X1, X2, Y X3 SON CADA UNO N, O, S Y CR; R ES H, ALQUILO C1-C4, ENTRE OTROS; R1 ES ANILLO CARBOCICLICO DE 5-8 MIEMBROS, R2 ES H, CH3, CH2-CH3, ENTRE OTROS; R3 Y R4 SON CADA UNO H, ALQUIL C1-C6, CICLOALQUILO C3-C7, ENTRE OTROS; R5 ES H, ALQUILO C1-C4, ENTRE OTROS; R5' ES H, ALQUILO C1-C4; R6 ES H, ALQUILO C1-C4, ALQUILOXI C1-C4, ENTRE OTROS; R7 ES H, CN, HALOGENO, ENTRE OTROS. SON PREFERIDOS: 7-CLORO-3-(5-{[N-ETIL-N-(2-METOXIETIL)AMINO]METIL}-[1,2,4]-TIADIAZOL-3-IL)-1-(TETRAHIDROPIRAN-4-IL)METIL-1H-INDOL; 7-CLORO-3-{5-[(2,2-DIMETIL-PIRROLIDIN-1-IL)METIL]-[1,2,4]OXADIAZOL-3-IL}-1-(TETRAHIDROPIRAN-4-IL)METIL-1H-INDOL; ENTRE OTROS. DICHOS COMPUESTOS SON AGONISTAS DEL RECEPTOR DE CANNABINOIDES CB1 UTILES EN EL TRATAMIENTO DEL DOLOR CRONICO, NEUROPATICO, DE CANCER, ENTRE OTROS
PE2005000245A 2004-03-05 2005-03-04 Derivados de (indol-3-il)-heterociclos PE20060074A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04100902 2004-03-05
EP04103901 2004-08-12

Publications (1)

Publication Number Publication Date
PE20060074A1 true PE20060074A1 (es) 2006-02-18

Family

ID=36608981

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2005000245A PE20060074A1 (es) 2004-03-05 2005-03-04 Derivados de (indol-3-il)-heterociclos

Country Status (20)

Country Link
US (1) US7700634B2 (es)
EP (1) EP1725232B1 (es)
JP (1) JP5011097B2 (es)
AR (1) AR048745A1 (es)
AT (1) ATE384525T1 (es)
AU (1) AU2005224041B2 (es)
BR (1) BRPI0508404A (es)
CA (1) CA2557054C (es)
DE (1) DE602005004515T2 (es)
DK (1) DK1725232T3 (es)
ES (1) ES2300995T3 (es)
MY (1) MY139070A (es)
NZ (1) NZ549386A (es)
PE (1) PE20060074A1 (es)
PL (1) PL1725232T3 (es)
PT (1) PT1725232E (es)
RS (1) RS20060502A (es)
SI (1) SI1725232T1 (es)
TW (1) TWI330635B (es)
WO (1) WO2005089754A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI330635B (en) 2004-03-05 2010-09-21 Organon Nv (indol-3-yl)-heterocycle derivatives
TW200745096A (en) * 2005-08-23 2007-12-16 Organon Nv Indole derivatives
US7763732B2 (en) 2005-08-24 2010-07-27 N.V. Organon Indole derivatives
GB0614062D0 (en) * 2006-07-14 2006-08-23 Glaxo Group Ltd Compounds
GB0614066D0 (en) * 2006-07-14 2006-08-23 Glaxo Group Ltd Compounds
TW200848417A (en) * 2007-02-22 2008-12-16 Organon Nv Indole derivatives
CN109689045A (zh) 2016-05-04 2019-04-26 因美制药公司 大麻素的局部制剂在治疗大疱性表皮松解症和相关结缔组织病症中的用途
WO2022128050A1 (en) 2020-12-14 2022-06-23 Symrise Ag Medicament for fighting inflammation and pain

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ227841A (en) * 1988-02-12 1991-08-27 Merck Sharp & Dohme Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions
US4939138A (en) 1988-12-29 1990-07-03 Sterling Drug Inc. 2- and 3-aminomethyl-6-arylcarbonyl-2,3-dihydropyrrolo(1,2,3-DE)-1,4-benzoxazines
AU2001234958A1 (en) * 2000-02-11 2001-08-20 Bristol-Myers Squibb Company Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
AUPR118000A0 (en) * 2000-11-02 2000-11-23 Amrad Operations Pty. Limited Therapeutic molecules and methods
DE60237431D1 (de) 2001-01-29 2010-10-07 Univ Connecticut Rezeptor-selektive cannabimimetische aminoalkylindole
TW200402417A (en) 2002-06-21 2004-02-16 Akzo Nobel Nv 1-[(Indol-3-yl)carbonyl]piperazine derivatives
US7772227B2 (en) 2003-12-17 2010-08-10 N.V. Organon Tricyclic 1-[(indol-3-yl)carbonyl]piperazine derivatives as cannabinoid CB1 receptor agonists
TWI330635B (en) 2004-03-05 2010-09-21 Organon Nv (indol-3-yl)-heterocycle derivatives
TW200745096A (en) 2005-08-23 2007-12-16 Organon Nv Indole derivatives
US7763732B2 (en) 2005-08-24 2010-07-27 N.V. Organon Indole derivatives
TW200848417A (en) 2007-02-22 2008-12-16 Organon Nv Indole derivatives

Also Published As

Publication number Publication date
TWI330635B (en) 2010-09-21
DE602005004515T2 (de) 2009-01-29
JP5011097B2 (ja) 2012-08-29
ES2300995T3 (es) 2008-06-16
SI1725232T1 (sl) 2008-06-30
WO2005089754A1 (en) 2005-09-29
TW200602316A (en) 2006-01-16
PL1725232T3 (pl) 2008-07-31
NZ549386A (en) 2009-12-24
ATE384525T1 (de) 2008-02-15
AU2005224041A1 (en) 2005-09-29
BRPI0508404A (pt) 2007-07-17
AU2005224041B2 (en) 2011-03-10
CA2557054A1 (en) 2005-09-29
CA2557054C (en) 2013-02-19
DE602005004515D1 (de) 2008-03-13
DK1725232T3 (da) 2008-05-26
EP1725232B1 (en) 2008-01-23
PT1725232E (pt) 2008-03-04
EP1725232A1 (en) 2006-11-29
RS20060502A (en) 2008-11-28
AR048745A1 (es) 2006-05-24
US7700634B2 (en) 2010-04-20
MY139070A (en) 2009-08-28
JP2007526281A (ja) 2007-09-13
US20070142446A1 (en) 2007-06-21

Similar Documents

Publication Publication Date Title
PE20060074A1 (es) Derivados de (indol-3-il)-heterociclos
RU2010151410A (ru) Производные аминодигидротиазина
TR200100378T2 (tr) P-maddesi aşırısının aracılık ettiği hastalıkların tedavisindeki ilaç
HUP0400963A2 (hu) Antidiarrheás és perifériális analgetikus hatású helyettesített ciklohexán-1,4-diamin-származékok felhasználása gyógyszerkészítmények előállítására
PE20081557A1 (es) Derivados de oxindol sustituido, medicamentos que los comprenden y uso de los mismos
DE60025189D1 (de) Cyanopyrrole als progesteronrezeptoragonisten
PE108898A1 (es) Derivados 6,5-heterobiciclicos sustituidos
BRPI0707491B8 (pt) compostos úteis como agentes moduladores de receptores de mineralocorticóides, os referidos agentes compreendendo os mesmos e composições farmacêuticas
HUP0303652A2 (hu) Ciklikus származékok, mint kemokin receptor aktivitás modulátorai és ezeket tartalmazó gyógyszerkészítmények
IL215027A0 (en) ANTI-zB7R1 ANTIBODY
EA200700047A1 (ru) Новые алкильные производные в качестве метаботропных рецепторов глутамата
PE20070187A1 (es) Moduladores de lxr basados en pirazol
UY25873A1 (es) Derivados de 3-azabiciclo [3.1.0] hexano útiles en terapia en afecciones mediadas por receptores opiáceos
ATE360631T1 (de) Azabicyclische heterocyclen als modulatoren des cannabinoidrezeptors
EA200301213A1 (ru) Лиганды рецепторов 5-ht и их применение
HUP0301573A2 (hu) Szubsztituált arilpirazinok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
ATE433454T1 (de) Pyrazoloä1,5-aüpyrimidine als antagonisten des adenosin-a2a-rezeptors
TNSN06203A1 (en) Derivatives of n- (1,5-diphenyl-1h-pyrazol-3-yl) sulphonamide with cb1 receptor affinity
PE20061351A1 (es) COMPUESTOS 8H-PIRIDO[2,3-d]PIRIMIDIN-7-ONA 2,4,8-TRISUSTITUIDOS COMO INHIBIDORES DE LA QUINASA CSBP/RK/p38
MXPA05007115A (es) Nuevos agonistas inversos del receptor cb 1.
ECSP088829A (es) Derivados de bencimidazol 5-sulfonamida como ligandos del receptor cannabinoide 1 (cb1)
PE20070236A1 (es) Derivados de indol como agonistas de receptor canabinoide
PE20060273A1 (es) Derivados de tetrahidroisoquinolilsulfonamidas como moduladores del receptor h3
PE20090112A1 (es) Derivados de indol como agonistas del receptor de canabinoides cb1
PE20030718A1 (es) Lactamas como antagonistas de taquiquininas

Legal Events

Date Code Title Description
FC Refusal